Search Within


Applied Filters:
Showing 1-7 of 7 results for "F0772" within Papers
Shanfeng Tan et al.
Molecular medicine reports, 18(2), 1305-1310 (2018-06-15)
Chemokines have been demonstrated to serve an important role in a variety of diseases, particularly in tumor progression. There have been numerous studies that have reported that T cells serve major roles in tumor progression. However, the function of CXC motif
Wolfgang Kern et al.
Cytometry. Part B, Clinical cytometry, 82(3), 145-150 (2011-12-07)
In patients with chronic lymphocytic leukemia (CLL), aberrant expression of the T-lineage antigen CD8 was reported in low frequencies. The clinical impact of this phenomenon remains in discussion. We analyzed 5,523 patients with CLL (21-97 years) by multiparametric flow cytometry
CXCL9 promotes prostate cancer progression through inhibition of cytokines from T cells
Tan S, et al.
Molecular Medicine Reports, 18(2), 1305-1310 (2018)
Christian Schütz et al.
Blood, 111(7), 3546-3552 (2007-12-22)
Several cell-based immunotherapy strategies have been developed to specifically modulate T cell-mediated immune responses. These methods frequently rely on the utilization of tolerogenic cell-based antigen-presenting cells (APCs). However, APCs are highly sensitive to cytotoxic T-cell responses, thus limiting their therapeutic
Marie-Agnès Doucey et al.
The Journal of biological chemistry, 278(5), 3257-3264 (2002-09-07)
T cells expressing T cell receptor (TCR) complexes that lack CD3 delta, either due to deletion of the CD3 delta gene, or by replacement of the connecting peptide of the TCR alpha chain, exhibit severely impaired positive selection and TCR-mediated
C L Kohem et al.
Arthritis and rheumatism, 39(5), 844-854 (1996-05-01)
To delineate in greater detail the phenotype of T cells that reside in the synovial tissue (ST) and synovial fluid (SF) of patients with rheumatoid arthritis (RA), in order to determine their precise differentiation status, and to determine whether the
G F Gao et al.
Immunology today, 21(12), 630-636 (2000-12-15)
In recent years, substantial progress has been made towards understanding the molecular basis for CD8 binding to class I MHC and the coreceptor's role in cytotoxic T-cell activation. Here, we review the structural, mechanistic and functional studies that point to
Page 1 of 1